CTSI Update
The Boston University Clinical and Translational Science Institute
(BU CTSI) has received a five-year, $38.3 million grant renewal from the Clinical and Translational Science Award Program.The BU CTSI was established in 2008 and is one of more than 50 institutions comprising the national CTSA Consortium led by the National Center for Advancing Translational Sciences , part of the NIH. We provide tools, services, and resources to clinical investigators to maximize the impact of discoveries and speed the translation of research into improved patient care through collaborative approaches.

New Funding Opportunities

Administrative Supplements to Existing NIH ECHO Cooperative Agreements Coronavirus Disease 2019 – related Research


 Funding Opportunity Announcements for the RADx-UPInitiatives


NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional)

Office of The Director, National Institutes of Health ( OD )

Funding Opportunity Announcement for Serological Sciences Centers of Excellence

National Cancer Institute ( NCI )

Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional)

Eunice Kennedy Shriver National Institute of Child Health and Human Development ( NICHD )

Through the Leo Foundation program, grants are awarded in support of research projects with potential to improve the understanding of the underlying medicinal, biological, chemical, or pharmacological mechanisms of dermatological diseases and their symptoms, and address clinical issues among people who are at risk of developing, or have developed, a skin disease, including how it impacts their quality of life and the societal costs involved.
.

The QuickFire challenge grants innovators up to $200,000 in support of ideas aimed at improving pregnancy, birth, and postpartum care for women, making birth safer in the United States and potentially changing the trajectory of health for a lifetime. In addition, awardees will receive access to the global JLABS network and mentorship from experts at the Johnson & Johnson Family of Companies.
News Highlights
Gathering Big Data to Accelerate
the COVID-19 Fight
The N3C aims to improve the efficiency and accessibility of analyses with COVID-19 clinical data, expand our ability to analyze and understand COVID, and demonstrate a novel approach for collaborative pandemic data sharing.

Researchers Can Join Forces with COVID-19 Collaboration Platform
The   COVID-19 Collaboration Platform  (CovidCP) brings unassociated research teams working on the same clinical research questions together to share protocols, data, and evidence.


Collaborative Research Efforts
NCATS and the CTSA Program Coordinating Centers have created a publicly accessible clinical research information platform with the aim of providing a centralized location of pre-clinicaltrials.gov investigational research studies.

Boston University Clinical & Translational Science Institute
Accelerating Discoveries Towards Better Health 
b u.edu/ctsi | ncats.nih.gov